gain from foreign exchange of THB 92 million from THB appreciation, but realized a few loss from Yen depreciation. The company also received income tax refund from 2007 as revenue of THB 226 million
Exchange Forward Contract in the amount of THB 255 million from the continuous appreciation of THB. Thus, EBITDA recorded was THB 781 million (+28% YoY, -1% QoQ). Refinery Business Marketing Business sales
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
No. MVP005/2020 21 February 2020 Subject: Management Discussion and Analysis for the year ended 31 December 2019 To: President and Manager The Stock Exchange of Thailand M Vision Public Company
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
December 31, 2019 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For Year Ended December 31, 2019 Overall Group Performance Table 1
share of net profit from investment by equity method and gain from currency exchange. The hotel business accounted for 86.5% of total revenue. Hotel management business accounted for 2.6%. Educational
No. ZIGA 002/2017 August 16, 2017 Subject: Clarification for operation performance for the three-month period (Quarter 2) ended 30 June 2017 Attention: The President of The Stock Exchange of Thailand
บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) - Translation - 14 August 2019 Subject : Disclosure of connected transaction by a subsidiary Attention : President The Stock Exchange of Thailand Vanachai Group Public